Vicente LLP Partner Charles Alovisetti to Discuss Cannabis Banking Compliance in Upcoming CLE BARBRI Program
Oct 16, 2025
On Wednesday, November 12, 2025, Vicente LLP partner Charles Alovisetti will join a panel of legal and banking professionals for the Barbri CLE course “Banking Issues in the Cannabis Industry: Managing Risks Under State and Federal Law; Recent Developments.” The 90-minute program begins at 1:00 PM ET and will include a live Q&A session.
About the Webinar
The CLE program will explore the ongoing tension between state-level cannabis legalization and federal laws that still categorize it as a controlled substance. Panelists will unpack the regulatory and enforcement risks banks and financial institutions face when dealing with cannabis-related businesses (CRBs).
Panelists include:
- Charles Alovisetti, Vicente LLP
- James K. Landau, Lachtman Cohen & Belowich LLP
- Jonathan S. Robbins, Akerman LLP
Attendees will also learn about the latest legislative updates, such as the Secure and Fair Enforcement Regulation (SAFER) Banking Act of 2025, which seeks to offer federal protections to financial institutions that serve state-legal cannabis businesses.
Additional topics include:
- Understanding Bank Secrecy Act (BSA) and Anti-Money Laundering (AML) obligations
- Complying with Know Your Customer (KYC) requirements
- Assessing lending risks tied to cannabis collateral
- Navigating enforcement and reporting under FIN-2014-G001 and related guidance
The course is designed for attorneys, compliance experts, and financial institution leaders seeking clarity on cannabis banking risks and opportunities within the evolving state and federal frameworks.
Register today to strengthen your understanding of cannabis banking compliance and regulation.
About Charles Alovisetti
Charlie Alovisetti is a partner at Vicente LLP and co-chair of the firm's Corporate Department. He advises investors, companies, and other law firms on complex corporate transactions across highly regulated industries, with a particular depth of experience in cannabis, hemp, psychedelics, and emerging consumer products. Learn more here.